Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
talc, FDA and asbestos
'A win': Pensacola attorney praises FDA's proposed rule for testing talc-based cosmetics
For decades, women thought they could trust cosmetic products, like baby powder, for feminine hygiene.But many of those products contai
FDA proposes new tests to detect asbestos in cosmetics and other products containing talc
The proposed rule is required under a law passed by Congress last year, and is intended to ensure the safety of makeup and baby powder.
US FDA proposes standardized testing to detect asbestos in talc products
The U.S. Food and Drug Administration is proposing that cosmetic products containing talc should be tested using standardized methods to detect asbestos, a potential contaminant, according to documents posted on the federal register on Thursday.
1d
on MSN
‘I felt betrayed’: Woman blames cancer diagnosis on talcum powder use
Exclusive: Jane Campbell is one of thousands of women in the UK planning legal action against one of the world’s largest ...
4d
What's Next For Johnson & Johnson's Talcum Powder Litigation?
Potential legal and legislative battles are sure to dominate Johnson & Johnson’s talcum powder litigation in 2025.
devdiscourse
3d
Health News Highlights: Talc Testing and Bird Flu Mutations
Recent health developments include the FDA's proposal for standardized testing of talc products for asbestos detection and ...
Kennebec Journal
4d
North Yarmouth widower sues J&J for $25M over talcum powder
A North Yarmouth widower has filed a $25 million lawsuit against Johnson & Johnson and Pecos River Talc after his wife contracted mesothelioma and died.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
FDA
asbestos
Food and Drug Administration
Johnson & Johnson
Reuters
Feedback